Get started
Author

Matthew T. Ye

Observed name: Matthew T Ye
ORCID: 0000-0002-1397-0968
Observed ORCID: 0000-0002-1397-0968
OpenAlex ID: A5001237141
Downregulation of FAPP2 gene induces cell autophagy and inhibits PI3K/AKT/mTOR pathway in T‐cell acute lymphoblastic leukemia
2021 · Tian Yuan, Jinhuan Wang, et al. · Hematological Oncology · 8
The Roles of Sirt1 in Breast and Gynecologic Malignancies
2025 · Jianmin Ding, Matthew T. Ye, et al. · Biology · 7
PDF
Integrated Clinical Genotype–Phenotype Characteristics of STAT3 -Mutated Myeloid Neoplasms
2024 · Matthew T. Ye, Zhuang Zuo, et al. · Clinical Cancer Research · 5
Integrated clinical genotype‐phenotype characteristics of early T‐cell precursor acute lymphoblastic leukemia
2022 · Matthew T. Ye, Yi Wang, et al. · Cancer · 5
Concurrent JAK2 V617F and MPL W515L in myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis
2019 · Matthew T. Ye, Yi Wang, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 4
B-Lymphoblastic Leukemia With Aberrant CD5 Expression
2020 · Matthew T Ye, Jia Zhu, et al. · American Journal of Clinical Pathology · 2
STAT3 / STAT5 Mutations Predict Shorter Overall Survival in Patients with Plasma Cell Myeloma
2026 · Matthew T. Ye, Zhuang Zuo, et al. · European Journal Of Haematology
Composite CLL/SLL and Lymphoplasmacytic Lymphoma with IgM Anti-MAG Neuropathy: Clinicopathologic and Molecular Characterization of a Diagnostically Challenging Case.
2026 · Ruimeng Yang, Matthew T Ye, et al. · PubMed
Composite Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Diagnostic and Therapeutic Challenge
2026 · Matthew T. Ye, Yaling Yang, et al. · eJHaem
PDF
Abstract 7175: STAT3/STAT5 mutation predicts shorter overall survival in patients with plasma cell myeloma
2025 · Matthew T. Ye, Zhuang Zuo, et al. · Cancer Research
Supplementary Table S3 from Integrated Clinical Genotype–Phenotype Characteristics of STAT3-Mutated Myeloid Neoplasms
2024 · Matthew T. Ye, Zhuang Zuo, et al.
Supplementary Table S1 from Integrated Clinical Genotype–Phenotype Characteristics of STAT3-Mutated Myeloid Neoplasms
2024 · Matthew T. Ye, Zhuang Zuo, et al.
Data from Integrated Clinical Genotype–Phenotype Characteristics of STAT3-Mutated Myeloid Neoplasms
2024 · Matthew T. Ye, Zhuang Zuo, et al.
Supplementary Table S2 from Integrated Clinical Genotype–Phenotype Characteristics of STAT3-Mutated Myeloid Neoplasms
2024 · Matthew T. Ye, Zhuang Zuo, et al.
Abstract 5053: Clinicopathologic and molecular genetic features of STAT3-mutated myeloid neoplasms
2024 · Matthew T. Ye, Zhuang Zuo, et al. · Cancer Research
Author response for "Downregulation of FAPP2 gene induces cell autophagy and inhibits PI3K/AKT/mTOR pathway in T‐cell acute lymphoblastic leukemia"
2021 · Tian Yuan, Jinhuan Wang, et al.
USP48 Inhibition as a Potential Therapeutic Target for Patients with T-acute Lymphoblastic Leukemia
2021 · Matthew T. Ye, Ya‐Ling Yang, et al.
ETP-ALL is an Aggressive Neoplasm with High Tumor Mutation Burden
2021 · Matthew T. Ye, Steliana Calin, et al.
Works count: 18
Citation count: 31
H-index: 4
I10-index:
Year
Topic
Type